Vincristine (Intravenous Route)

Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Vincristine (Intravenous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Oncovin
  • Vincasar PFS

Description

Vincristine belongs to the group of medicines known as antineoplastic agents. It is used to treat some kinds of cancer as well as some noncancerous conditions.

Vincristine interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by vincristine, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, such as hair loss, may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.

Before you begin treatment with vincristine, you and your doctor should talk about the good this medicine will do as well as the risks of using it.

Vincristine is to be administered only by or under the immediate supervision of your doctor.

This product is available in the following dosage forms:

  • Powder for Solution
  • Solution
Before Using

DR601433

Portions of this document last updated:

Nov. 1, 2009

Source: Drug Information provided by: Micromedex

Copyright © 2009 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.


Text Size: smaller largerlarger